Loring Wolcott & Coolidge Fiduciary Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Loring Wolcott & Coolidge Fiduciary Advisors's RGEN Position: Q1 2023 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Repligen (RGEN) in Q1 2023, closing a stake of 34 shares — an estimated $5.76K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RGEN in Q2 2021 and held it in 3 quarters. The position peaked at $5.76K in Q4 2022. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 34 Repligen shares in Q1 2023, an estimated $5.76K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Repligen in Q2 2021 and held it in 3 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Repligen position peaked at $5.76K in Q4 2022.
- 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2023, filed 2 May 2023.